Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Ascendis Pharma A/S will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, providing a business update [1] - A live webcast of the presentation will be available on the Ascendis Pharma website, with a replay accessible for 30 days post-event [2] Company Overview - Ascendis Pharma is a global biopharmaceutical company focused on its innovative TransCon technology platform to develop new therapies addressing unmet medical needs [3] - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [3]